402 related articles for article (PubMed ID: 25912721)
21. Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
Kaye RS; Purewal TS; Alpar HO
J Pharm Sci; 2009 Nov; 98(11):4055-68. PubMed ID: 19189420
[TBL] [Abstract][Full Text] [Related]
22. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
23. Polymer- and liposome-based nanoparticles in targeted drug delivery.
Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
[TBL] [Abstract][Full Text] [Related]
24. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages.
Costa A; Sarmento B; Seabra V
Eur J Pharm Sci; 2018 Mar; 114():103-113. PubMed ID: 29229273
[TBL] [Abstract][Full Text] [Related]
25. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
Gupta U; Jain NK
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
27. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
28. Active Nano-targeting of Macrophages.
Gaspar N; Zambito G; Löwik CMWG; Mezzanotte L
Curr Pharm Des; 2019; 25(17):1951-1961. PubMed ID: 31291874
[TBL] [Abstract][Full Text] [Related]
29. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.
Chono S; Kaneko K; Yamamoto E; Togami K; Morimoto K
Drug Dev Ind Pharm; 2010 Jan; 36(1):102-7. PubMed ID: 19656002
[TBL] [Abstract][Full Text] [Related]
30. Targeted Drug Delivery Systems for Lung Macrophages.
Costa A; Sarmento B; Seabra V
Curr Drug Targets; 2015; 16(14):1565-81. PubMed ID: 25395103
[TBL] [Abstract][Full Text] [Related]
31. The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages.
Lawlor C; O'Sullivan MP; Sivadas N; O'Leary S; Gallagher PJ; Keane J; Cryan SA
Mol Pharm; 2011 Aug; 8(4):1100-12. PubMed ID: 21591762
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel drug delivery systems.
Zhang Z; Mei L; Feng SS
Expert Opin Drug Deliv; 2013 Mar; 10(3):325-40. PubMed ID: 23289542
[TBL] [Abstract][Full Text] [Related]
33. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
Oberdorster G
Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
[TBL] [Abstract][Full Text] [Related]
34. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
[TBL] [Abstract][Full Text] [Related]
35. The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles.
Rabolli V; Badissi AA; Devosse R; Uwambayinema F; Yakoub Y; Palmai-Pallag M; Lebrun A; De Gussem V; Couillin I; Ryffel B; Marbaix E; Lison D; Huaux F
Part Fibre Toxicol; 2014 Dec; 11():69. PubMed ID: 25497724
[TBL] [Abstract][Full Text] [Related]
36. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
37. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
[TBL] [Abstract][Full Text] [Related]
38. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
Luo MX; Hua S; Shang QY
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
[TBL] [Abstract][Full Text] [Related]
39. Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung.
Zhao J; Qin L; Song R; Su J; Yuan Y; Zhang X; Mao S
Eur J Pharm Biopharm; 2022 Mar; 172():101-111. PubMed ID: 35149189
[TBL] [Abstract][Full Text] [Related]
40. Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer.
Mukhtar M; Ali H; Ahmed N; Munir R; Talib S; Khan AS; Ambrus R
Expert Opin Drug Deliv; 2020 Sep; 17(9):1239-1257. PubMed ID: 32543950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
